OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, et al.
Intestinal Research (2022) Vol. 21, Iss. 1, pp. 110-125
Open Access | Times Cited: 15
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, et al.
Intestinal Research (2022) Vol. 21, Iss. 1, pp. 110-125
Open Access | Times Cited: 15
Showing 15 citing articles:
Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy
Olga Maria Nardone, Irene Zammarchi, Giovanni Santacroce, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2389-2389
Open Access | Times Cited: 30
Olga Maria Nardone, Irene Zammarchi, Giovanni Santacroce, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2389-2389
Open Access | Times Cited: 30
Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan
Shintaro Akiyama, Kaoru Yokoyama, Soichi Yagi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 11, pp. 1413-1424
Closed Access | Times Cited: 12
Shintaro Akiyama, Kaoru Yokoyama, Soichi Yagi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 11, pp. 1413-1424
Closed Access | Times Cited: 12
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Hyuk Yoon, Byong Duk Ye, Sang‐Bum Kang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Hyuk Yoon, Byong Duk Ye, Sang‐Bum Kang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors
Alexander Goetsch, Ferdinando D’Amico, Mariangela Allocca, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 7, pp. 849-861
Open Access | Times Cited: 10
Alexander Goetsch, Ferdinando D’Amico, Mariangela Allocca, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 7, pp. 849-861
Open Access | Times Cited: 10
Quercus infectoria galls mitigates colitis in mice through alleviating mucosal barrier impairment and suppressing inflammatory factors
Yan Ding, Jiaojiao Bai, Sabahat Ablimit, et al.
Journal of Ethnopharmacology (2025) Vol. 343, pp. 119487-119487
Closed Access
Yan Ding, Jiaojiao Bai, Sabahat Ablimit, et al.
Journal of Ethnopharmacology (2025) Vol. 343, pp. 119487-119487
Closed Access
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data
Katsuyoshi Matsuoka, Satoshi Motoya, Takayuki Yamamoto, et al.
Journal of Gastroenterology (2025)
Open Access
Katsuyoshi Matsuoka, Satoshi Motoya, Takayuki Yamamoto, et al.
Journal of Gastroenterology (2025)
Open Access
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 9, pp. 874-887
Open Access | Times Cited: 8
Stefan Schreiber, Gerhard Rogler, Mamoru Watanabe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 9, pp. 874-887
Open Access | Times Cited: 8
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
A Massano, Luisa Bertin, Fabiana Zingone, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3824-3824
Open Access | Times Cited: 6
A Massano, Luisa Bertin, Fabiana Zingone, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3824-3824
Open Access | Times Cited: 6
Recent advances in anti-inflammatory active components and action mechanisms of natural medicines
Zhimin Wu, Tao Zhang, Xiaofei Ma, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 2901-2937
Closed Access | Times Cited: 6
Zhimin Wu, Tao Zhang, Xiaofei Ma, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 2901-2937
Closed Access | Times Cited: 6
Understanding the efficacy of individual Janus kinase inhibitors in the treatment of ulcerative colitis for future positioning in inflammatory bowel disease treatment
Hiroshi Nakase
Immunological Medicine (2023) Vol. 46, Iss. 3, pp. 121-130
Open Access | Times Cited: 5
Hiroshi Nakase
Immunological Medicine (2023) Vol. 46, Iss. 3, pp. 121-130
Open Access | Times Cited: 5
Real-World Data on the Effectiveness and Safety of Filgotinib for Ulcerative Colitis in Japanese Patients: A Single-Center Experience
Takahito Toba, Ryo Karashima, Kodai Fujii, et al.
Cureus (2024)
Open Access | Times Cited: 1
Takahito Toba, Ryo Karashima, Kodai Fujii, et al.
Cureus (2024)
Open Access | Times Cited: 1
Xihuang pill ameliorates colitis in mice by improving mucosal barrier injury and inhibiting inflammatory cell filtration through network regulation
Meng-Lei Hu, Qian-Zan Liao, Bo-Tong Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117098-117098
Open Access | Times Cited: 3
Meng-Lei Hu, Qian-Zan Liao, Bo-Tong Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117098-117098
Open Access | Times Cited: 3
Filgotinib for moderately to severely active ulcerative colitis
Alessandro Mannucci, Ferdinando D’Amico, Ahmad El Saadi, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 10, pp. 927-940
Closed Access | Times Cited: 5
Alessandro Mannucci, Ferdinando D’Amico, Ahmad El Saadi, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 10, pp. 927-940
Closed Access | Times Cited: 5
Patients’ Preference on Advanced Therapy and Follow-Up Procedure for Inflammatory Bowel Disease in Japan: A Web-Based 3A Survey
Toshifumi Morishita, Shunichi Yanai, Yosuke Toya, et al.
Inflammatory Intestinal Diseases (2024) Vol. 9, Iss. 1, pp. 174-183
Open Access
Toshifumi Morishita, Shunichi Yanai, Yosuke Toya, et al.
Inflammatory Intestinal Diseases (2024) Vol. 9, Iss. 1, pp. 174-183
Open Access
The role and prospect of tofacitinib in patients with ulcerative colitis
Jun Lee
Intestinal Research (2022) Vol. 21, Iss. 1, pp. 168-169
Open Access | Times Cited: 1
Jun Lee
Intestinal Research (2022) Vol. 21, Iss. 1, pp. 168-169
Open Access | Times Cited: 1
